Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Ferreira, P.C.L., Bellaver, B., Povala, G., Brum, W.S., Tissot, C., Badji, A., Sloan, M.E., Benedet, A.L., Rosa-Neto, P., Ashton, N.J., Pascoal, T.A., Leuzy, A. & Zimmer, E.R. 2023. Endocannabinoid System Biomarkers in Alzheimer's Disease. Cannabis Cannabinoid Res, 8(1):77-91.

Gowin, J.L., Sloan, M.E., Kirk-Provencher, K.T., Rosenblatt, S.L., Penner, A.E., Stangl, B.L., Byrd, N.D., Swan, J.E. & Ramchandani, V.A. 2023. Opioid Receptor Antagonism and Neural Response to Monetary Rewards: Pilot Studies in Light and Heavy Alcohol Users. J Psychopharmacol, 37(9):937-941.

Stellern, J., Xiao, K.B., Grennell, E., Sanches, M., Gowin, J.L. & Sloan, M.E. 2023. Emotion Regulation in Substance Use Disorders: A Systematic Review and Meta-Analysis. Addiction, 118(1):30-47.

Tang, V.M., Goud, R., Zawertailo, L., Selby, P., Coroiu, A., Sloan, M.E., Chenoweth, M.J., Buchman, D., Ibrahim, C., Blumberger, D.M. & Le Foll, B. 2023. Repetitive Transcranial Magnetic Stimulation for Smoking Cessation: Next Steps for Translation and Implementation into Clinical Practice. Psychiatry Res, 326:115340.

Tang, V.M., Yu, D., Weissman, C.R., Jones, B.D.M., Wang, G., Sloan, M.E., Blumberger, D.M., Daskalakis, Z.J., Le Foll, B. & Voineskos, D. 2023. Treatment Outcomes in Major Depressive Disorder in Patients with Comorbid Alcohol Use Disorder: A Star*D Analysis. J Affect Disord, 339:691-697.

Xiao, K.B., Grennell, E., Ngoy, A., George, T.P., Le Foll, B., Hendershot, C.S. & Sloan, M.E. 2023. Cannabis Self-Administration in the Human Laboratory: A Scoping Review of Ad Libitum Studies. Psychopharmacology (Berl), 240(7):1393–1415.